The VSA Capital, Aquis Showcase Event
17/11/2022 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221117:nRSQ7468Ga&default-theme=true
RNS Number : 7468G S-Ventures PLC 17 November 2022
17 November 2022
S-VENTURES PLC
("S-Ventures" or the "Company")
The VSA Capital, Aquis Showcase Event
S-Ventures, the company investing in and growing exciting brands across the
natural, wellness and food-tech category, is pleased to announce that the
Company will be presenting at The VSA Capital, Aquis Showcase Event on 29
November 2022 at the Royal College of Surgeons of England, 38-43 Lincoln's Inn
Fields, London, WC2A 3PE. The Company is looking forward to meeting existing
and future shareholders at the event.
20 companies will be presenting during the course of the day and will be split
into 4 groups and given 10 minutes each to pitch their business case to the
audience, who will vote for their favourites using a QR code. The Company will
give a presentation between 12:00-12:45 on 29 November.
For further information on The VSA Capital Aquis Showcase Event and to
register for tickets, please visit The VSA Capital, Aquis Showcase Event
Tickets, Tue 29 Nov 2022 at 08:00 | Eventbrite
(https://link.edgepilot.com/s/670f163a/FRamzsDtaECzPYLHJtn8Bg?u=https://www.eventbrite.co.uk/e/the-vsa-capital-aquis-showcase-event-tickets-430890363677?aff=odeimcmailchimp%26mc_eid=72e11c608b%26mc_cid=7349fe017a)
For further information, please contact:
The Company +44 (0) 1932 400 224
Robert Hewitt (Chief Financial Officer)
Scott Livingston (Chief Executive Officer)
AQSE Corporate Adviser and Broker: +44 (0) 20 3005 5000
VSA Capital Limited
Andrew Raca - Corporate Finance
Andrew Monk - Corporate Broking
IFC Advisory (Financial PR) +44 (0) 20 3934 6630
Graham Herring
Tim Metcalfe
Florence Chandler
About S-Ventures
S-Ventures is listed on UK AQUIS Exchange (Ticker Code "SVEN"). The Company
seeks to identify investment opportunities in the health & wellness,
organic food and wellbeing sectors within the UK and Europe, adding value by
providing capital and expertise to the target companies. The experience and
operational skills of the Board led by Scott Livingston (CEO) are intended to
act as an accelerator to smaller brands that have a solid foundation and
platform but may lack the skills and capital. The main objectives are to
cross-fertilise opportunities between the target companies and scale the
individual entities and look for exit opportunities and/or synergistic
collaborations through scaling we seek to create significant value for all
stakeholders. Since listing on AQSE in September 2020, the Company has
acquired significant interests in seven companies.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NEXBKOBBABDKCDD